The global, regional, and national burden and quality of care index of kidney cancer; a global burden of disease systematic analysis 1990-2019.

IF 2.7 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Mohamad Mehdi Khadembashiri, Erfan Ghasemi, Mohammad Amin Khadembashiri, Sina Azadnajafabad, Sahar Saeedi Moghaddam, Mohamad Eslami, Mohammad-Mahdi Rashidi, Mohammadreza Naderian, Zahra Esfahani, Naser Ahmadi, Nazila Rezaei, Sahar Mohammadi Fateh, Farzad Kompani, Bagher Larijani, Farshad Farzadfar
{"title":"The global, regional, and national burden and quality of care index of kidney cancer; a global burden of disease systematic analysis 1990-2019.","authors":"Mohamad Mehdi Khadembashiri, Erfan Ghasemi, Mohammad Amin Khadembashiri, Sina Azadnajafabad, Sahar Saeedi Moghaddam, Mohamad Eslami, Mohammad-Mahdi Rashidi, Mohammadreza Naderian, Zahra Esfahani, Naser Ahmadi, Nazila Rezaei, Sahar Mohammadi Fateh, Farzad Kompani, Bagher Larijani, Farshad Farzadfar","doi":"10.1093/intqhc/mzad113","DOIUrl":null,"url":null,"abstract":"<p><p>Kidney cancer (KC) is a prevalent cancer worldwide. The incidence and mortality rates of KC have risen in recent decades. The quality of care provided to KC patients is a concern for public health. Considering the importance of KC, in this study, we aim to assess the burden of the disease, gender and age disparities globally, regionally, and nationally to evaluate the quality and inequities of KC care. The 2019 Global Burden of Disease study provides data on the burden of the KC. The secondary indices, including mortality-to-incidence ratio, disability-adjusted life years -to-prevalence ratio, prevalence-to-incidence ratio, and years of life lost-to-years lived with disability ratio, were utilized. These four newly merged indices were converted to the quality-of-care index (QCI) as a summary measure using principal component analysis. QCI ranged between 0 and 100, and higher amounts of QCI indicate higher quality of care. Gender disparity ratio was calculated by dividing QCI for females by males to show gender inequity. The global age-standardized incidence and mortality rates of KC increased by 29.1% (95% uncertainty interval 18.7-40.7) and 11.6% (4.6-20.0) between 1990 and 2019, respectively. Globally, the QCI score for KC increased by 14.6% during 30 years, from 71.3 to 81.6. From 1990 to 2019, the QCI score has increased in all socio-demographic index (SDI) quintiles. By 2019, the highest QCI score was in regions with a high SDI (93.0), and the lowest was in low SDI quintiles (38.2). Based on the World Health Organization regions, the QCI score was highest in the region of America, with Canada having the highest score (99.6) and the lowest in the African Region, where the Central African Republic scored the lowest (17.2). In 1990, the gender disparity ratio was 0.98, and in 2019, it was 0.97 showing an almost similar QCI score for females and males. Although the quality of care for KC has improved from 1990 to 2019, there is a significant gap between nations and different socioeconomic levels. This study provides clinicians and health authorities with a global perspective on the quality of care for KC and identifies the existing disparities.</p>","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal for Quality in Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/intqhc/mzad113","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Kidney cancer (KC) is a prevalent cancer worldwide. The incidence and mortality rates of KC have risen in recent decades. The quality of care provided to KC patients is a concern for public health. Considering the importance of KC, in this study, we aim to assess the burden of the disease, gender and age disparities globally, regionally, and nationally to evaluate the quality and inequities of KC care. The 2019 Global Burden of Disease study provides data on the burden of the KC. The secondary indices, including mortality-to-incidence ratio, disability-adjusted life years -to-prevalence ratio, prevalence-to-incidence ratio, and years of life lost-to-years lived with disability ratio, were utilized. These four newly merged indices were converted to the quality-of-care index (QCI) as a summary measure using principal component analysis. QCI ranged between 0 and 100, and higher amounts of QCI indicate higher quality of care. Gender disparity ratio was calculated by dividing QCI for females by males to show gender inequity. The global age-standardized incidence and mortality rates of KC increased by 29.1% (95% uncertainty interval 18.7-40.7) and 11.6% (4.6-20.0) between 1990 and 2019, respectively. Globally, the QCI score for KC increased by 14.6% during 30 years, from 71.3 to 81.6. From 1990 to 2019, the QCI score has increased in all socio-demographic index (SDI) quintiles. By 2019, the highest QCI score was in regions with a high SDI (93.0), and the lowest was in low SDI quintiles (38.2). Based on the World Health Organization regions, the QCI score was highest in the region of America, with Canada having the highest score (99.6) and the lowest in the African Region, where the Central African Republic scored the lowest (17.2). In 1990, the gender disparity ratio was 0.98, and in 2019, it was 0.97 showing an almost similar QCI score for females and males. Although the quality of care for KC has improved from 1990 to 2019, there is a significant gap between nations and different socioeconomic levels. This study provides clinicians and health authorities with a global perspective on the quality of care for KC and identifies the existing disparities.

肾癌的全球、地区和国家负担及护理质量指数 (QCI);1990-2019 年全球疾病负担系统分析。
背景:肾癌是一种全球流行的癌症。近几十年来,肾癌(KC)的发病率和死亡率均有所上升。为肾癌患者提供的护理质量是公共卫生关注的焦点。考虑到肾癌的重要性,在本研究中,我们旨在评估全球、地区和国家的疾病负担、性别和年龄差异,以评估肾癌护理的质量和不公平现象:方法:2019 年全球疾病负担研究提供了有关 KC 负担的数据。该研究采用了二级指数,包括死亡率与发病率之比、残疾调整生命年(DALYs)与患病率之比、患病率与发病率之比以及丧失生命年(YLLs)与残疾生存年(YLDs)之比。利用主成分分析法(PCA)将这四项新合并的指数转换为护理质量指数(QCI),作为一项综合指标。QCI 介于 0 和 100 之间,QCI 值越高,表示护理质量越高。用女性的 QCI 除以男性的 QCI,计算出性别差异比(GDR),以显示性别不平等:结果:1990 年至 2019 年期间,全球 KC 年龄标准化发病率和死亡率分别增加了 29.1%(95% 不确定区间为 18.7 至 40.7)和 11.6%(4.6 至 20.0)。在全球范围内,KC 的 QCI 分数在 30 年间增加了 14.6%,从 71.3 升至 81.6。从 1990 年到 2019 年,所有社会人口指数(SDI)五分位数的 QCI 分数都有所上升。到 2019 年,SDI 指数高的地区 QCI 得分最高(93.0),SDI 指数低的五分位数地区 QCI 得分最低(38.2)。根据世界卫生组织的地区划分,QCI 得分最高的是美洲地区,加拿大得分最高(99.6),最低的是非洲地区,中非共和国得分最低(17.2)。1990年,GDR为0.98,2019年为0.97,显示女性和男性的QCI得分几乎相似:尽管从 1990 年到 2019 年,肾癌的治疗质量有所提高,但不同国家和不同社会经济水平之间仍存在明显差距。这项研究为临床医生和卫生部门提供了肾癌治疗质量的全球视角,并确定了现存的差距。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.90
自引率
3.80%
发文量
87
审稿时长
6-12 weeks
期刊介绍: The International Journal for Quality in Health Care makes activities and research related to quality and safety in health care available to a worldwide readership. The Journal publishes papers in all disciplines related to the quality and safety of health care, including health services research, health care evaluation, technology assessment, health economics, utilization review, cost containment, and nursing care research, as well as clinical research related to quality of care. This peer-reviewed journal is truly interdisciplinary and includes contributions from representatives of all health professions such as doctors, nurses, quality assurance professionals, managers, politicians, social workers, and therapists, as well as researchers from health-related backgrounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信